<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:j="http://www.w3.org/2005/xpath-functions"><head><meta charset="UTF-8"/><title>dea:DEAClassScheduleCodeCodeSimpleType</title><style type="text/css">body { font-family: Helvetica, "Helvetica Neue", Arial, sans-serif; } div#page { text-align: center; } div#content { text-align: left; display: inline-block; } div.ns-defn { margin-left: 2em; } div.xml-schema div.line:first-letter { margin-left: -2em; } div.xml-schema div.line { margin-left: 2em; } div.xml-schema div.block div.block { margin-left: 1em; } div.json-schema div.line:first-letter { margin-left: -2em; } div.json-schema div.line { margin-left: 2em; } div.json-schema div.block div.block { margin-left: 1em; } h1 { font-size: 120%; } h2 { font-size: 110%; } h3 { font-size: 100%; } table { border-collapse: collapse; border-style: solid; } td { border-style: solid; border-width: 1px; }</style></head><body><div id="page"><div id="content"><h1><a href="../index.html">dea</a>:DEAClassScheduleCodeCodeSimpleType</h1><p>simpleType DEAClassScheduleCodeCodeSimpleType in namespace http://release.niem.gov/niem/codes/dea_ctlsub/4.0/</p><h2>Definition</h2><p>A data type for a class to which the Drug Enforcement Agency (DEA) has assigned the product under the Controlled Substances Act of 1970.</p><h2>Diagram</h2><a name="diagram"><div style="text-align: center;"><img src="data:image/png;base64,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" usemap="#graphic"/></div></a><map id="graphic" name="graphic">
<area shape="rect" id="node2_2" href="../../dea/DEAClassScheduleCodeCodeType/index.html#diagram" title="A data type for a class to which the Drug Enforcement Agency (DEA) has assigned the product under the Controlled Substances Act of 1970." alt="" coords="37,170,251,187"/>
<area shape="rect" id="node3_3" href="../../xs/token/index.html#diagram" title="&lt;TABLE&gt;" alt="" coords="121,7,167,25"/>
</map><h2>Enumerations</h2><a name="enumerations"><table><thead><tr><td>Value</td><td>Definition</td></tr></thead><tbody><tr><td>I</td><td>Schedule I Controlled Substances.  Substances in this schedule have no currently accepted medical use in the United States, a lack of accepted safety for use under medical supervision, and a high potential for abuse.</td></tr><tr><td>II</td><td>Schedule II Controlled Substances.  Substances in this schedule have a high potential for abuse which may lead to severe psychological or physical dependence.</td></tr><tr><td>III</td><td>Schedule III Controlled Substances.  Substances in this schedule have a potential for abuse less than substances in Schedules I or II and abuse may lead to moderate or low physical dependence or high psychological dependence.</td></tr><tr><td>IV</td><td>Schedule IV Controlled Substances.  Substances in this schedule have a low potential for abuse relative to substances in Schedule III.</td></tr><tr><td>V</td><td>Schedule V Controlled Substances.  Substances in this schedule have a low potential for abuse relative to substances listed in Schedule IV and consist primarily of preparations containing limited quantities of certain narcotics.</td></tr></tbody></table></a><h2>XML Schema</h2><a name="xml-schema"><div class="xml-schema"><div class="block"><div class="line">&lt;xs:simpleType name="DEAClassScheduleCodeCodeSimpleType"&gt;</div><div class="block"><div class="line">&lt;xs:annotation&gt;</div><div class="block"><div class="line">&lt;xs:documentation&gt;</div>A data type for a class to which the Drug Enforcement Agency (DEA) has assigned the product under the Controlled Substances Act of 1970.<div class="line">&lt;/xs:documentation&gt;</div></div><div class="line">&lt;/xs:annotation&gt;</div></div><div class="block"><div class="line">&lt;xs:restriction base="<a href="../../xs/token/index.html#xml-schema">xs:token</a>"&gt;</div><div class="block"><div class="line">&lt;xs:enumeration value="I"&gt;</div><div class="block"><div class="line">&lt;xs:annotation&gt;</div><div class="block"><div class="line">&lt;xs:documentation&gt;</div>Schedule I Controlled Substances.  Substances in this schedule have no currently accepted medical use in the United States, a lack of accepted safety for use under medical supervision, and a high potential for abuse.<div class="line">&lt;/xs:documentation&gt;</div></div><div class="line">&lt;/xs:annotation&gt;</div></div><div class="line">&lt;/xs:enumeration&gt;</div></div><div class="block"><div class="line">&lt;xs:enumeration value="II"&gt;</div><div class="block"><div class="line">&lt;xs:annotation&gt;</div><div class="block"><div class="line">&lt;xs:documentation&gt;</div>Schedule II Controlled Substances.  Substances in this schedule have a high potential for abuse which may lead to severe psychological or physical dependence.<div class="line">&lt;/xs:documentation&gt;</div></div><div class="line">&lt;/xs:annotation&gt;</div></div><div class="line">&lt;/xs:enumeration&gt;</div></div><div class="block"><div class="line">&lt;xs:enumeration value="III"&gt;</div><div class="block"><div class="line">&lt;xs:annotation&gt;</div><div class="block"><div class="line">&lt;xs:documentation&gt;</div>Schedule III Controlled Substances.  Substances in this schedule have a potential for abuse less than substances in Schedules I or II and abuse may lead to moderate or low physical dependence or high psychological dependence.<div class="line">&lt;/xs:documentation&gt;</div></div><div class="line">&lt;/xs:annotation&gt;</div></div><div class="line">&lt;/xs:enumeration&gt;</div></div><div class="block"><div class="line">&lt;xs:enumeration value="IV"&gt;</div><div class="block"><div class="line">&lt;xs:annotation&gt;</div><div class="block"><div class="line">&lt;xs:documentation&gt;</div>Schedule IV Controlled Substances.  Substances in this schedule have a low potential for abuse relative to substances in Schedule III.<div class="line">&lt;/xs:documentation&gt;</div></div><div class="line">&lt;/xs:annotation&gt;</div></div><div class="line">&lt;/xs:enumeration&gt;</div></div><div class="block"><div class="line">&lt;xs:enumeration value="V"&gt;</div><div class="block"><div class="line">&lt;xs:annotation&gt;</div><div class="block"><div class="line">&lt;xs:documentation&gt;</div>Schedule V Controlled Substances.  Substances in this schedule have a low potential for abuse relative to substances listed in Schedule IV and consist primarily of preparations containing limited quantities of certain narcotics.<div class="line">&lt;/xs:documentation&gt;</div></div><div class="line">&lt;/xs:annotation&gt;</div></div><div class="line">&lt;/xs:enumeration&gt;</div></div><div class="line">&lt;/xs:restriction&gt;</div></div><div class="line">&lt;/xs:simpleType&gt;</div></div></div></a><h2>JSON Schema</h2><a name="json-schema"><div class="json-schema"/></a><h3>Notes</h3><p xmlns:json="http://www.w3.org/2005/xpath-functions">JSON Schema for this component has not been defined.</p></div></div></body></html>